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OBJECTIVE—To examine the hypothesis that vitamin D deﬁciency (VDD) is associated with
an increased prevalence of microvascular complications in young people with type 1 diabetes.
RESEARCH DESIGN AND METHODS—In a cross-sectional study of 517 patients,
25-hydroxyvitamin D was measured. Retinopathy was assessed by 7-ﬁeld stereoscopic retinal
photography, peripheral neuropathy by thermal and vibration threshold testing, and micro-
albuminuria by albumin excretion rate or albumin-to-creatinine ratio.
RESULTS—Retinopathy prevalence was higher in cases with VDD versus sufﬁciency (18 vs.
9%, P =0 . 0 2 ) ;d e ﬁciency was not associated with microalbuminuria or neuropathy. In logistic
regression,retinopathywasassociatedwithVDD(odds ratio2.12[95%CI 1.03–4.33]),diabetes
duration (1.13, 1.05–1.23), and HbA1c (1.24, 1.02–1.50).
CONCLUSIONS—VDD is associated with an increased prevalence of retinopathy in young
people with type 1 diabetes. The inﬂammatory and angiogenic effects of VDD may contribute to
early retinal vascular damage; however, further investigations are warranted.
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V
itamin D deﬁciency (VDD) has been
implicated in the development of
diabetes complications based on
studies in mice, cell cultures, and adults
with diabetes (1–6). Vitamin D may confer
protection via inhibition of inﬂammation,
downregulation of the renin-angiotensin
system, improved insulin secretion, and
an antiproliferative effect on endothelial
cells (1). In a mouse model of ischemic
retinopathy, 1,25-dihydroxyvitamin D3
[1,25(OH)2D3] inhibited retinal neovascu-
larization (5), while in cell culture it inhib-
ited endothelial cell proliferation (6). The
severityofdiabeticretinopathywasinversely
related to serum 1,25(OH)2D3 levels in
adults with type 2 diabetes (2). However
there are no studies examining vitamin
D and complications in young people. We
examined the hypothesis that vitamin D
deﬁciency is associated with microvascu-
lar complications in adolescents with type
1 diabetes.
RESEARCH DESIGN AND
METHODS—This was a cross-sectional
study of 517 adolescents aged 8–20 years
attending the Diabetes Complications As-
sessment Service (DCAS) at the Children’s
HospitalatWestmead,Westmead,Australia,
from2009to2010.Thestudyreceivedeth-
ical approval from the Children’s Hospital
at Westmead.
Retinopathy was assessed using 7-
ﬁeld stereoscopic fundal photography
and deﬁned as at least one microaneu-
rysm or hemorrhage (7). Neuropathy in
the foot was assessed by thermal thresh-
old and vibration threshold testing
(NeuroSensory TSA-II and Vibratory
Sensory Analyzer; Medoc Ltd., Ramat
Yishai,Israel).Presenceofperipheralneu-
ropathy was determined using published
dataonthermalperceptiontestinginchil-
dren and adolescents using the same
equipment (8). Microalbuminuria was
assessed, as previously described (7).
Elevated albumin excretion rate/albumin-
to-creatinine ratio (AER/ACR) was deﬁned
as AER $7.5 mg/min in at least 2/3 over-
nighturinesorameanACR$1.0mg/mmol
(males) and $1.4 mg/mmol (females). The
AER/ACR equivalent thresholds were de-
rived from data on 7,170 adolescents with
diabetes (T. Jones, Perth, Australia, personal
communication).
Total 25-hydroxyvitamin D (25-
OHD) was measured using the LIAISON
analyzer (DiaSorin Inc., Stillwater, MN).
Levels were seasonally adjusted using
correction factors obtained from multiple
linear regression of 550 samples from
healthy children from Sydney, Australia;
summer (27.71), autumn (5.14), winter
(5.03), spring (22.46). VDD was deﬁned
as#50nmol/L(9).HemoglobinA1c(HbA1c)
was measured using the Bio-Rad Diamat
analyzer (Bio-Rad, Hercules, CA).
IndividualswereclassiﬁedasCaucasian/
non-Caucasian using the Australian Bureau
of Statistics (ABS) standards for classifying
the ethnic and cultural composition of the
Australian population (10). Socioeconomic
status was determined by postcodes using
the ABS Socio-Economic Indexes for Areas
(10).Logisticregressionwasusedtoexam-
ine factors associated with complications
(PASW, V18, IBM, Chicago, IL).
RESULTS—Vitamin D levels were per-
formed on 495/517 (96%) patients, with
mean6SDage14.962.4years,diabetes
duration 7.2 6 3.5 years, and median
HbA1c 8.6 6 1.5%. Mean 6 SD 25-
OHD level was 70.1 6 23 nmol/L and
80/495 (16%) were deﬁcient. Retinopa-
thy was more common in young people
with VDD compared with their sufﬁcient
counterparts (18 vs. 9%, P = 0.02), but
there were no between-group differences
for elevated AER/ACR, microalbumin-
uria, or peripheral nerve function. Sex,
age, diabetes duration, BMI standard
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BRIEF REPORTdeviation score(SDS), systolic blood pres-
sure (SBP) SDS, diastolic blood pressure
(DBP) SDS, HbA1c, cholesterol, insulin
dose/weight, C-reactive protein, preva-
lence of celiac disease, and socioeconomic
status also did not differ between groups.
Factors associated with retinopathy, ab-
normal peripheral nerve function, and el-
evated AER/ACR are in Table 1.
CONCLUSIONS—This is the ﬁrst
study to our knowledge of young people
with type 1 diabetes to demonstrate an
association between VDD and diabetic
retinopathy, independent of diabetes du-
rationandHbA1c.However,VDDwasnot
associated with abnormal peripheral
nerve function or elevated AER/ACR.
We speculate that the angiogenic effect
of VDD contributes to retinal vascular
damage, whereas renal vessels and pe-
ripheral nerves may be less susceptible.
This novel association is supported by
studies of adults with type 2 diabetes and
more advanced retinopathy; 1,25(OH)2D3
levels were inversely correlated with a
higher grade of retinopathy (2), and
lower 25-OHD levels were associated
with proliferative retinopathy (3). The
current ﬁnding suggests that VDD may
have a permissive role in earlier stages of
retinopathy.
Biological models support a causal
role for VDD in proliferative retinopathy,
which is characterized by neovascular-
ization and angiogenesis. Higher serum
1,25(OH)2D3 was associated with reduced
angiogenesis in both a transgenic retino-
blastoma model and ischemic retinopathy
inmice(5,11).Thismaybeexplainedbyan
interactionbetweenvitaminDandvascular
endothelial growth factor (VEGF); the addi-
tionof1,25(OH)2D3reducedVEGF-induced
proliferationinaorticendothelialcellcul-
ture (6).
ThevitaminDreceptor(VDR)ispres-
ent in the human retina, and polymor-
phisms of VDR are related to retinopathy
risk in type 1 diabetes. The Fok 1 single
nucleotide polymorphism of the VDR
gene was associated with increased tran-
scriptional activity of the VDR and less
severe diabetic retinopathy (12), and in-
dividuals with the TT genotype of the
VDR Taq 1polymorphism werelesslikely
to have retinopathy (13). We did not ex-
amine genetic risk factors in our popula-
tion;infuturestudiesitwouldbevaluable
to examine the relationship between
genes involved in vitamin D metabolism
and retinopathy.
We cannot exclude the possibility
thatVDDisaconfounderforotherfactors
contributingtoretinopathy.Forexample,
VDD may mask the effect of ethnicity on
retinopathy, given that lower vitamin D is
associated with darker skin pigmentation
and higher retinopathy rates are found in
Hispanic, African American, and South
Asianpeople(14).However,wefoundno
relationship between ethnicity and reti-
nopathy.
Because of the cross-sectional nature
of this study, we cannot assume a causal
relationship between VDD and retinopa-
thy. Indeed, it is possible that VDD is a
consequence of retinopathy because in-
dividuals with complications may be less
mobileandhavelowersunexposure.This
is unlikely, however, because the study
population consisted of adolescents who
were otherwise well, and only early com-
plications were detected. Although, this
study is clinic-based, the individuals at-
tending DCAS comprise approximately
one-third of cases in the state of New
South Wales (15).
In conclusion, this study demonstrates
a novel association between VDD and reti-
nopathy in children and adolescents with
type1diabetes.Thisissupportedbyclinical,
biological, and genetic data; however, pro-
spective studies are required to validate this
relationship and elucidate the underlying
mechanisms.
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